Logo.png
Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark
15 juil. 2020 09h00 HE | Guardion Health Sciences, Inc.
The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests San Diego, California, July 15, 2020 (GLOBE NEWSWIRE) --...
Logo.png
Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease
08 juil. 2020 08h45 HE | Guardion Health Sciences, Inc.
Patent Application Will Add to Guardion’s Intellectual Property Portfolio San Diego, California, July 08, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
Logo.png
Guardion Health Sciences Completes Delivery of $875,000 Order to Malaysian Corporate Customer
30 juin 2020 05h00 HE | Guardion Health Sciences, Inc.
Fulfills Initial Order of Astramern from Astramune Sdn Bhd, a Subsidiary of Ho Wah Genting Berhad San Diego, California, June 30, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc....
Logo.png
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
07 janv. 2020 11h02 HE | Guardion Health Sciences, Inc.
San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
Logo.png
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019
14 nov. 2019 07h00 HE | Guardion Health Sciences, Inc.
Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...